Try our Advanced Search for more refined results
Searching dockets in Superior Biologics Inc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Contract: Other | Pennsylvania Eastern
Order ~Util - Set Motion and R&R Deadlines/Hearings
ORDER THAT UPON CONSIDERATION OF PLAINTIFFS' LETTER DATED OCTOBER 5, 2026 (DKT. NO. 26 ), THE LETTER SHALL BE CONSTRUED AS A MOTION TO SUPPLEMENT THE RECORD, AND THE MOTION IS GRANTED. NO LATER THAN OCTOBER 28, 2026, DEFENDANT SHALL SUPPLEMENT HER MOTION TO DISMISS WITH A BRIEF ADDRESSING THE EFFECT, IF ANY, OF THE COMPLAINT SHE FILED IN THE SUPREME COURT OF THE STATE OF NEW YORK ON SEPTEMBER 30, 2026, ON THE INSTANT ACTION. ETC. PLAINTIFFS SHALL FILE A RESPONSE TO DEFENDANT'S SUPPLEMENTAL BRIEF NO LATER THAN NOVEMBER 18, 2026. ETC.. SIGNED BY DISTRICT JUDGE GAIL A WEILHEIMER ON 10/8/26. 10/9/26 ENTERED AND COPIES E-MAILED.(va)
Civil Rights: Jobs | New York Southern
Notice of Appearance
NOTICE OF APPEARANCE by Daniel J. LaRose on behalf of CSSRX Holdings, Inc., Raymons A Mirra, Payer Matrix, Inc., Superior Biologics NY, Inc., Superior Biologics, Inc...(LaRose, Daniel)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.